NCT05260541 - A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

September 23, 2022

Conditions

Post-traumatic Stress DisorderPost Traumatic Stress DisorderStress DisorderStress Disorders, Post-TraumaticTrauma and Stressor Related DisordersMental Disorder

Interventions

DRUG

60 mg PRAX-114 or 40 mg PRAX-114

Once daily oral treatment for 4 weeks

DRUG

Placebo

Once daily oral treatment for 4 weeks

DRUG

40 mg PRAX-114

Once daily oral treatment for 8 weeks

Trial Locations (17)

18104

Praxis Research Site, Allentown

19063

Praxis Research Site, Media

30030

Praxis Research Site, Decatur

33908

Praxis Research Site, Fort Myers

45219

Praxis Research Site, Cincinnati

45417

Praxis Research Site, Dayton

72211

Praxis Research Site, Little Rock

72758

Praxis Research Site, Rogers

73118

Praxis Research Site, Oklahoma City

75231

Praxis Research Site, Dallas

78737

Praxis Research Site, Austin

85012

Praxis Research Site, Phoenix

89102

Praxis Research Site, Las Vegas

91362

Praxis Research Site, Westlake Village

91945

Praxis Research Site, Lemon Grove

98201

Praxis Research Site, Everett

02131

Praxis Research Site, Boston